Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Front Cell Infect Microbiol. 2021 May 12;11:563126. doi: 10.3389/fcimb.2021.563126. eCollection 2021.
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and is characterized by a hyperinflammatory state accompanied by immunosuppression. Long noncoding RNAs (lncRNAs) are noncoding RNAs longer than 200 nucleotides and have important roles in mediating various biological processes. Recently, lncRNAs were found to exert both promotive and inhibitory immune functions in sepsis, thus participating in sepsis regulation. Additionally, several studies have revealed that lncRNAs are involved in sepsis-induced organ dysfunctions, including cardiovascular dysfunction, acute lung injury, and acute kidney injury. Considering the lack of effective biomarkers for early identification and specific treatment for sepsis, lncRNAs may be promising biomarkers and even targets for sepsis therapies. This review systematically highlights the recent advances regarding the roles of lncRNAs in sepsis and sheds light on their use as potential biomarkers and treatment targets for sepsis.
脓毒症是一种危及生命的器官功能障碍,由宿主对感染的失调反应引起,其特征是伴发免疫抑制的过度炎症状态。长链非编码 RNA(lncRNA)是长度大于 200 个核苷酸的非编码 RNA,在介导各种生物学过程中具有重要作用。最近发现,lncRNA 在脓毒症中既具有促进免疫功能的作用,也具有抑制免疫功能的作用,从而参与脓毒症的调控。此外,一些研究表明,lncRNA 参与了脓毒症引起的器官功能障碍,包括心血管功能障碍、急性肺损伤和急性肾损伤。鉴于目前缺乏用于早期识别和特异性治疗脓毒症的有效生物标志物,lncRNA 可能是有前途的生物标志物,甚至是脓毒症治疗的靶点。本综述系统地强调了 lncRNA 在脓毒症中的作用的最新进展,并探讨了它们作为脓毒症潜在生物标志物和治疗靶点的用途。